You must be logged in to Real Money to view these timely and actionable videos.

Already a Subscriber? Please login to see videos.

Not a Subscriber? Watch these videos and take advantage of the full breadth of Real Money coverage by clicking the button below.

Columnist Conversations

This morning we are seeing PBYI up 270% to 218 on Phase 3 results for their breast cancer drug neratnib. Price...
Markets seem to be taking breaking news going across wire that two Ukrainian militaryfighter jets have been sh...
Lang:
As I was away on vacation last week I still kept one eye on the markets and with my technological devices at h...
We are currently testing the key resistance decision in ICE. Do not consider an entry without a trigger!! ...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.